WO2010058815A1 - 血液成分測定装置 - Google Patents
血液成分測定装置 Download PDFInfo
- Publication number
- WO2010058815A1 WO2010058815A1 PCT/JP2009/069622 JP2009069622W WO2010058815A1 WO 2010058815 A1 WO2010058815 A1 WO 2010058815A1 JP 2009069622 W JP2009069622 W JP 2009069622W WO 2010058815 A1 WO2010058815 A1 WO 2010058815A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blood component
- test piece
- blood
- measuring device
- component measuring
- Prior art date
Links
- 239000012503 blood component Substances 0.000 title claims abstract description 72
- 239000008280 blood Substances 0.000 claims abstract description 234
- 210000004369 blood Anatomy 0.000 claims abstract description 234
- 238000012360 testing method Methods 0.000 claims abstract description 157
- 238000005259 measurement Methods 0.000 claims abstract description 89
- 239000000306 component Substances 0.000 claims abstract description 7
- 230000003287 optical effect Effects 0.000 claims description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 147
- 239000008103 glucose Substances 0.000 abstract description 147
- 210000003811 finger Anatomy 0.000 description 58
- 238000000034 method Methods 0.000 description 19
- 238000010586 diagram Methods 0.000 description 11
- 238000012986 modification Methods 0.000 description 11
- 230000004048 modification Effects 0.000 description 11
- 210000000707 wrist Anatomy 0.000 description 9
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 210000004247 hand Anatomy 0.000 description 3
- 210000003813 thumb Anatomy 0.000 description 3
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- -1 2-hydroxy-3-sulfopropyl Chemical group 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000013523 data management Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/08—Sensors provided with means for identification, e.g. barcodes or memory chips
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Definitions
- the present invention relates to a blood component measuring apparatus for measuring a component such as glucose from blood collected through a blood introduction path in a test piece attached to a tip attaching portion.
- the blood glucose level is measured by providing a measuring section such as a test paper impregnated with a reagent that is colored according to the amount of glucose in the blood, supplying blood to the test paper to cause coloration, and determining the degree of coloration.
- a blood glucose meter that obtains and displays a blood glucose level by optical measurement has been put into practical use (for example, Utility Model Registration No. 3135393 (FIGS. 2 and 8), JP 2000-46834 A, US (See Japanese Patent No. 7077328).
- the test paper is provided on a disposable test piece, and the test piece is mounted on the tip mounting portion of the blood glucose meter.
- a blood glucose meter using an electrochemical sensor has also been put into practical use.
- the skin eg, finger, palm, etc.
- a predetermined puncture device e.g., a puncture device
- a small amount of blood is allowed to flow out after puncture.
- the test piece is attached to the blood glucose meter, the spotted portion at the tip of the test piece is brought into contact with the blood ball, and blood is introduced to the test paper by capillary action through a small diameter passage.
- the recent blood glucose meter is measured by medical staff for multiple patients who are admitted to a medical facility, in addition to personal use for diabetic patients themselves to measure blood glucose on a daily basis. There is a request for in-hospital use.
- the blood ball 900 obtained by puncture in one hand (hereinafter referred to as the left hand) is kept facing upward so as not to drop, but the blood glucose meter 901 and the test held by the right hand
- the piece 902 faces obliquely upward (see the arrow in FIG. 21), and it is difficult to hit the tip spotted portion 903 against the blood ball 900.
- the blood ball 900 is set substantially upward, the blood glucose meter 901 is approached from above or obliquely from above the blood ball 900.
- the blood drop 900 and the spotted portion 903 of the test piece 902 become blind spots by the blood glucose meter 901 and the right hand, resulting in poor visibility and difficult spotting operation. Since the spotted portion of the test piece is an operation target portion at the time of blood glucose measurement, visibility during operation is required, and visibility is also required for state confirmation when placed on a table.
- the blood glucose meter when placed on the table, it can be spotted with blood after the spotted portion has been brought close to the blood ball in advance.
- some blood glucose meters have a function of storing a plurality of blood glucose measurement values, but in a medical facility, it is assumed that one blood glucose meter is used for blood glucose measurement of a plurality of patients. It is necessary to store the blood glucose level separately for each patient. Moreover, it is desirable to be able to identify the operator who performed blood glucose measurement for each measurement for so-called traceability recording. Thus, in order to specify a patient and a user, it is necessary to read the identification information into a blood glucose meter.
- identification information can be acquired quickly and stably without giving a sense of incongruity to the patient.
- the barcode reader is provided at the tip, there is a concern that the laser light generated during the scan may be directed toward the patient and give the patient a sense of incongruity.
- the test piece attached to the tip measurement unit is applied to some other object (including a living body) when reading the barcode. There is a possibility that. If it is before blood glucose level measurement, there is a concern that the spotted part of the test piece is soiled or damaged and correct measurement cannot be performed. After blood glucose level measurement, blood adheres to the spotting part, and other objects that come into contact with it are soiled.
- the tip part is considerably large and unbalanced, and the gripping part is behind the monitor, so that it is far from the tip measurement unit, and as a result
- the tip measurement unit tends to be unstable.
- the present invention has been made in consideration of such problems, and it is possible to easily and surely contact a spotted portion of a test piece with a blood ball obtained by puncture to suppress measurement errors. It is a first object to provide a blood component measuring device that can be used, and a second object is to provide a blood component measuring device that can easily, quickly and stably read data.
- the blood component measurement device is a blood component measurement device to which a test piece is attached, wherein a tip mounting portion to which the test piece is attached and a blood introduction path in the test piece attached to the tip mounting portion. And a monitor for displaying the results obtained by the measurement unit and the predetermined control unit, with the display surface of the monitor on the upper side and the opposite side on the lower side.
- the center axis of the test piece is directed obliquely downward toward the tip when the monitor is placed on a horizontal surface with the display surface of the monitor facing upward.
- the center axis of the test piece is directed obliquely downward toward the tip side, so that the spotted portion of the test piece points in the direction of the blood ball. It becomes easy, the spotting part of a test piece can be contacted easily and reliably with respect to the blood ball obtained by puncture, and a measurement error can be suppressed.
- the blood component measuring device is a blood component measuring device to which a test piece is attached, and a blood introduction into the tip mounting portion to which the test piece is attached and the test piece attached to the tip mounting portion.
- a measuring unit that measures a component of blood collected through a path, and a monitor that displays a result obtained by the measuring unit and a predetermined control unit, the display surface of the monitor being on the upper side and the opposite side
- the center axis of the test piece is directed obliquely downward toward the distal end with reference to an extension line of the display surface of the monitor in a side view.
- the spotted portion of the test piece is in the direction of the blood ball.
- the spotted portion of the test piece can be easily and reliably brought into contact with the blood ball obtained by puncturing, and measurement errors can be suppressed.
- the angle between the extension line and the central axis may be 10 ° to 40 °. According to such an angle setting, the spotted portion of the test piece points the direction of the blood ball more correctly.
- a main portion provided with the monitor, and a relay portion provided between the main portion and the tip mounting portion, and an upper surface of the relay portion may be set substantially parallel to the central axis. .
- a space for providing several mechanisms related to the tip mounting part is ensured in a suitable direction, and by providing the relay part, the central axis of the test piece is directed obliquely downward toward the tip side. Easy to make.
- the orientation of the test piece can be easily grasped visually.
- An ejector lever for removing the mounted test piece by performing an extrusion operation toward the tip side may be provided on the upper surface of the relay unit. As a result, the ejector lever moves along the upper surface, and it becomes easy to operate, and the movement space of the ejector lever can be secured.
- the relay part may be continuous and concave from the main part and narrow toward the tip side.
- the relay portion becomes moderately thin and has a concave shape, so that it is easy to grip with the fingertip.
- the mounted test piece can be stabilized by gripping the relay part.
- the main part may have a substantially constant thickness in the vertical direction, and the main part and the relay part may be connected by a continuous curved surface having a concave bottom surface in a side view. It is easy to put a finger on such a concave and continuous curved surface, and it is easy to grasp the blood component measuring device.
- the distance between the tip spotted portion of the test piece and the horizontal plane is 3 mm to 30 mm. Also good.
- the blood glucose meter can be moved close to the blood ball while being placed on the table, so that blood spotting can be performed. Blood glucose measurement can be easily performed even for a handicapped patient.
- the visibility of the spotted part is good, and the state can be confirmed.
- the distance between the highest point on the lower surface and the horizontal surface may be 3 mm to 20 mm. As a result, an appropriate gap is ensured for putting a finger when it is placed on the table, making it easier to grip.
- test piece When the test piece is mounted on the tip mounting portion and placed on a horizontal surface with the display surface of the monitor facing upward, the test piece may be separated from the horizontal surface. Thereby, unnecessary external force is not applied to the test piece.
- the blood component measuring apparatus has a shape in which the center axis of the test piece is directed obliquely downward toward the distal end when placed on a horizontal surface (in other words, an extension line of the display surface of the monitor).
- the center axis is oriented obliquely downward toward the tip side), so that the spotted portion of the test piece can easily point in the direction of the blood ball, and the blood ball obtained by puncture
- the spotted portion of the test piece can be contacted easily and reliably, and measurement errors can be suppressed.
- the blood component measurement device is a blood component measurement device to which a test piece is attached, wherein a tip mounting portion to which the test piece is attached and a blood introduction path in the test piece attached to the tip mounting portion.
- a measurement unit for measuring a blood component collected via the monitor, a monitor for displaying a result obtained by the measurement unit and a predetermined control unit, a data reading optical means provided at the rear end, and the monitor And a relay portion provided between the main portion and the tip mounting portion, and a connecting portion between the main portion and the relay portion, and a curved surface portion having a concave bottom surface in side view.
- the data reading optical means By providing the data reading optical means at the rear end portion, it is directed away from the tip mounting portion and directed in the reverse direction, so that it is possible to prevent the test piece from being applied to some other object during data reading. Further, the concave curved surface portion can be used as a gripping portion, and since it is close to the tip mounting portion, it is easy to match the spotted portion of the test piece with the blood ball, and stable operation is possible. As described above, according to the blood component measuring apparatus of the present invention, data can be read simply, quickly and stably.
- the operation switch of the data reading optical means may be provided between the monitor and the tip mounting portion on the surface where the monitor is provided.
- the space between the monitor and the tip mounting part is a place where the operation switch can be easily operated, and is suitable for providing the operation switch. Further, since the operation switch is provided at this position, it is not necessary to change the hand position during the blood component measurement operation and the data reading operation, which is efficient.
- the operation switch is substantially on the opposite side of the curved surface portion, and can be held and operated stably by being sandwiched between a finger (for example, an index finger) applied to the curved surface portion and a finger (for example, a thumb) that presses the operation switch.
- the data reading optical means may be a bar code reader.
- the data reading optical means may be a camera that reads a two-dimensional code.
- the relay part may be continuous and concave from the main part and narrow toward the tip side.
- the relay portion becomes moderately thin and has a concave shape, so that it is easy to grip with the fingertip.
- the relay part since the relay part is close to the tip mounting part, by gripping the relay part, the blood ball can easily come into contact with the spotted part of the mounted test piece, and a stable operation can be performed.
- the center axis of the test piece is directed obliquely downward toward the tip side in a side view, with the extension line of the display surface of the monitor as a reference May be.
- the spotted portion of the test piece is in the direction of the blood ball.
- the spotted portion of the test piece can be easily and reliably brought into contact with the blood ball obtained by puncturing, and measurement errors can be suppressed.
- the blood component measurement apparatus enables simple data reading without contact. Further, the connector connection operation or the like is unnecessary, and data can be read quickly.
- the data reading optical means is provided at the rear end portion, it is opposite to the test piece and the measurement portion at the front end and is opposite to the patient, which may give the patient a sense of incongruity. Few.
- a curved surface portion having a concave bottom surface is provided at the connecting portion between the main portion and the relay portion, the finger is applied to stabilize the blood component measuring device. Therefore, optical reading by the data reading optical means is stably performed.
- FIG. 1 is a perspective view of a blood glucose meter according to the present embodiment.
- FIG. 2 is a plan view of the blood glucose meter according to the present embodiment.
- FIG. 3 is a side view of the blood glucose meter according to the present embodiment.
- FIG. 4 is an enlarged perspective view of the rear end portion of the blood glucose meter according to the present embodiment.
- FIG. 5 is a cross-sectional view of the test piece.
- FIG. 6 is a side view of the blood glucose meter in a state where a finger is put in the curved surface portion and held.
- FIG. 7 is a schematic diagram of the blood glucose meter in a state where the relay unit is gripped.
- FIG. 1 is a perspective view of a blood glucose meter according to the present embodiment.
- FIG. 2 is a plan view of the blood glucose meter according to the present embodiment.
- FIG. 3 is a side view of the blood glucose meter according to the present embodiment.
- FIG. 4 is an enlarged perspective view of the
- FIG. 8 is a diagram illustrating a state where a medical worker reads his / her measurer identification data using a blood glucose meter.
- FIG. 9 is a diagram illustrating a state where a medical worker reads patient identification data using a blood glucose meter.
- FIG. 10 is a schematic diagram of a stage before the left and right wrists or the vicinity thereof are placed on the table, the blood glucose meter is gripped, and the spotting operation is performed.
- FIG. 11 is a schematic diagram of a state where left and right wrists or the vicinity thereof are placed on a table, a blood glucose meter is gripped, and a spotting operation is performed.
- FIG. 10 is a schematic diagram of a stage before the left and right wrists or the vicinity thereof are placed on the table, the blood glucose meter is gripped, and the spotting operation is performed.
- FIG. 11 is a schematic diagram of a state where left and right wrists or the vicinity thereof are placed on a table, a blood glucose meter is
- FIG. 12 is a schematic diagram in which one finger is placed on a table and a spotting operation is performed by a blood glucose meter placed on the table.
- FIG. 13 is a schematic diagram in which two fingers are placed on a table and a spotting operation is performed by a blood glucose meter placed on the table.
- FIG. 14 is a schematic diagram of a state where a medical worker is performing a spotting operation on a patient.
- FIG. 15 is a schematic diagram of a state where a medical worker is performing a spotting operation on a patient.
- FIG. 16 is a perspective view of a blood glucose meter according to a first modification.
- FIG. 17 is a perspective view of a test piece applied to the blood glucose meter according to the first modification.
- FIG. 18 is a plan view of a blood glucose meter according to a second modification.
- FIG. 19 is a side view of a blood glucose meter according to a second modification.
- FIG. 20 is a perspective view of a blood glucose meter according to a third modification.
- FIG. 21 is a schematic diagram of a first example in which a spotting operation is performed by a blood glucose meter according to the prior art.
- FIG. 22 is a schematic diagram of a second example in which a spotting operation is performed by a blood glucose meter according to the related art.
- FIGS. 1 to 20 an embodiment of the blood component measuring apparatus according to the present invention will be described with reference to FIGS. 1 to 20.
- a blood glucose meter (blood component measuring device) 10a As shown in FIG. 1, FIG. 2, FIG. 3 and FIG. 4, a blood glucose meter (blood component measuring device) 10a according to the present embodiment has a test piece 12 attached to the tip.
- the blood glucose meter 10a has a function of storing a plurality of blood glucose measurement values.
- one blood glucose meter 10a can be used for blood glucose measurement of a plurality of patients.
- the test piece 12 will be described.
- the test piece 12 includes a base tube 14, a flange 16 that covers one of the base tubes 14, a conical protrusion 18 that protrudes from the flange 16, and a test paper that is attached to the back surface of the flange 16. 20.
- the base tube 14 is provided with a plurality of slits 14a (see FIG. 1). In the center of the protrusion 18, a straight blood introduction path 24 that communicates from the spotted portion 22 at the tip to the test paper 20 is provided.
- Examples of the material of the test paper 20 include polyethersulfone.
- Examples of the reagent impregnated in the test paper 20 include color formers such as glucose oxidase (GOD), peroxidase (POD), 4-aminoantipyrine, and N-ethyl N- (2-hydroxy-3-sulfopropyl). It is done.
- the reagent may contain a predetermined buffer.
- the blood introduction path 24 is generally provided on the central axis C of the test piece 12.
- the central axis C of the test piece 12 is a direction in which the spotting portion 22 of the test piece 12 faces and is a straight line passing through the tip of the spotting portion 22.
- the test piece 12 is a so-called disposable product, which is packaged in an individual package (not shown) and sterilized in advance.
- the blood introduction path 24 is set to have a sufficiently small diameter so that blood is sucked up by capillary action, and introduces the blood in contact with the spotting portion 22 to the test paper 20.
- a conventional product can be applied as it is.
- the blood glucose meter 10a is connected to the distal end mounting part 30 to which the test piece 12 is attached and the blood introduction path 24 in the test piece 12 attached to the distal end mounting part 30.
- An ejector lever 36 for removing the test piece 12 mounted by pushing out toward the distal end side, an operation button group 38, a data reading button 40, and a cap 39 for protecting the distal end mounting portion 30 are provided.
- the blood glucose meter 10a has a smooth shape with no corners as a whole. Since it becomes complicated, the cap 39 is omitted except for FIG.
- the measurement unit 32 can employ various mechanisms according to the component detection method of the test piece 12.
- the blood glucose meter 10a is used in a hospital where a medical staff measures a plurality of patients admitted to a medical facility, and is provided with a data recording / calling function for each patient and a button therefor. It is slightly larger than the personal use blood glucose meter 10c (see FIG. 18). Of course, the blood glucose meter 10a can be used for personal use without any special modification.
- the tip mounting portion 30 has a cylindrical shape because the test piece 12 is mounted, and the test piece 12 can be easily and stably mounted by inserting the base tube 14 (see FIG. 5).
- the blood glucose meter 10a is controlled by an internal control unit 33, and continuously projects and receives light on the test paper 20 by the measurement unit 32 constituted by optical means, and a predetermined color based on the coloration is obtained.
- the blood sugar level is obtained by calculation and displayed on the monitor 34.
- a predetermined error display is performed.
- the control procedure of blood glucose level measurement by the blood glucose meter 10a is basically the same as that of the blood glucose meter according to the prior art.
- the monitor 34 includes a blood glucose level display unit 34a that displays a blood glucose level, and an auxiliary display unit 34b that displays time and other information.
- the blood glucose level display unit 34a can display a three-digit number and a predetermined character display (for example, “OK”). Since some diabetics have weak visual acuity, the monitor 34 is set sufficiently large in consideration of visibility.
- the auxiliary display unit 34b also displays patient identification data, operator identification data, and test piece identification data read by a bar code reader 48 described later.
- the monitor 34 is at least a liquid crystal display surface.
- the operation button group 38 is collectively provided on the proximal end side, and includes a power button 38a, movement buttons 38b and 38c, selection buttons 38d and 38e, and an LED display unit 38f.
- the movement buttons 38b and 38c have functions such as moving an item displayed on the monitor 34 or scrolling the screen along with the movement.
- the selection buttons 38d and 38e have functions such as selecting a function displayed on the monitor 34 corresponding to each position.
- the LED display unit 38f has a function of notifying the state of the blood glucose meter by turning on and blinking in various colors by the LED.
- the ejector lever 36 is provided on the upper surface 46a in the vicinity of the distal end mounting portion 30 and is a round lever having a size suitable for placing a finger. And have.
- the ejector lever 36 is movable along the upper surface 46a.
- the flat portion 36a is provided with a plurality of lateral stripes to prevent slipping.
- the protrusion 36b has a width and a height suitable for applying a fingertip.
- the ejector lever 36 is elastically biased toward the proximal end side by a moderately weak elastic body. When the finger is pushed and pushed out toward the distal end side, the ejector lever 36 moves parallel to the axial direction of the cylindrical distal end mounting portion 30.
- the test piece 12 can be pushed out in conjunction with the internal ejector mechanism and removed from the tip mounting portion 30. Moreover, according to such a structure, the dirt can be easily wiped off.
- the data reading button 40 is an operation switch of a bar code reader (data reading optical means) 48 provided at the rear end.
- the data reading button 40 is a surface on which the monitor 34 is provided (hereinafter also referred to as a monitor surface), and is easily operated when provided between the monitor 34 and the tip mounting portion 30. Further, since the data reading button 40 is provided at this position, it is not necessary to change the hand position between the blood component measurement operation and the data reading operation, which is efficient.
- a plurality of data reading buttons 40 may be provided at close positions in accordance with applications (for example, for reading patient identification data, for reading measurement person identification data, and for reading test piece identification data). Further, different processes may be executed depending on the operation method (difference in switch-on time, difference in the number of switch-on times in a predetermined short time, etc.).
- a barcode reader 48 is provided in the recess 49 at the rear end of the blood glucose meter 10a.
- the barcode reader 48 is means for reading a barcode as patient identification data, measurer identification data, and test piece identification data by laser scanning.
- the bar code reader 48 is a general laser type and is inexpensive.
- the rear end of the blood glucose meter 10a is inclined so as to spread toward the monitor surface when viewed from the side (see FIG. 3). Since the bar code reader 48 is provided at the inclined rear end portion and in the concave portion 49, it is not inadvertently touched (see FIG. 6), and the measurement surface is not easily soiled.
- the blood glucose meter 10 a has a function of storing a plurality of blood glucose measurement values, and can store the blood glucose measurement values for each patient based on the patient identification data read by the barcode reader 48. Further, because of so-called traceability recording, it is possible to identify the operator who has performed blood glucose measurement for each measurement based on the measurer identification data read by the barcode reader 48. Furthermore, it can be confirmed that the proper test piece 12 is used based on the identification data specifying the type of the test piece 12. Information read by the barcode reader 48 is distinguished by the operation method of the data reading button 40 and is displayed separately on the monitor 34. In the blood glucose meter 10a, it is assumed that the barcode reader 48 reads patient identification data, measurer identification data, and test piece identification data, and then shifts to a predetermined measurement mode. Thereby, measurement is started by a correct procedure.
- the bar code reader 48 is provided at the rear end portion, it is opposite to the test piece 12 and the measurement portion 32 at the front end along the arrow A and is opposite to the patient. There is little discomfort. Moreover, since it is provided in the reverse direction, it is easy to use blood glucose measurement and data reading properly.
- the relay unit 46 can be made thin appropriately.
- an auxiliary function button used for a function specific to hospital use may be provided.
- the display surface of the monitor 34 is on the upper side, and the opposite side is on the lower side.
- the direction of the blood glucose meter 10a at the time of use and storage is not limited to this.
- the housing of the blood glucose meter 10a is mainly configured by combining an upper housing 42a provided with a monitor 34 and an operation button group 38 and a lower housing 42b constituting a lower portion.
- a small protrusion 43 is provided in a portion of the lower housing 42b that contacts the table T.
- the blood glucose meter 10a is divided into a main part 44 provided with the monitor 34 and the operation button group 38 and a relay part 46 provided between the main part 44 and the tip mounting part 30 in a top view (see FIG. 2). can do.
- the relay portion 46 is configured to be continuous and concave from the main portion 44 and narrow toward the distal end side, and the distal end mounting portion 30 is provided on the distal end surface.
- the data reading button 40 is provided just at the boundary between the main portion 44 and the relay portion 46 and is easy to touch and operate.
- the main part 44 is provided with a monitor 34 and has a certain width, but is wide enough to be gripped by human hands.
- the main portion 44 has a substantially constant width in the length direction (the direction of arrow A in FIGS. 2 and 3) when viewed from the top (see FIG. 2) and substantially constant in the vertical direction when viewed from the side (see FIG. 3). It is easy to grip.
- the blood glucose meter 10a has a bilaterally symmetric shape and can be easily grasped by either the right hand or the left hand.
- the blood glucose meter 10 a can also hold the relay part 46 in addition to the main part 44.
- the relay portion 46 is continuous and concave from the main portion 44 and narrows toward the distal end side, and is moderately thin and concave. . Further, since the relay unit 46 is close to the tip mounting unit 30, the mounted test piece 12 can be stabilized by gripping the relay unit 46.
- the relay unit 46 has a space in which several mechanisms related to the tip mounting unit 30 (for example, a measurement unit 32 for the test paper 20, an ejection mechanism of the test piece 12, a mechanism for holding the tip mounting unit 30, etc.) are suitable.
- the central axis C of the test piece 12 can easily be directed obliquely downward toward the tip side.
- the upper surface 46a of the relay part 46 is set substantially parallel to the central axis C of the test piece 12, and it is easy to visually grasp the orientation of the test piece 12.
- an ejector lever 36 is provided on the upper surface 46a of the relay portion 46, and the ejector lever 36 operates along the upper surface 46a, which makes it easy to operate, and provides a space for moving the ejector lever 36. It can be secured.
- the display surface of the monitor 34 is the upper side, the opposite side is the lower side, and the center axis C is obliquely downward toward the tip side with reference to the extension line L of the display surface of the monitor 34.
- the central axis C of the test piece 12 is directed obliquely downward toward the distal end side.
- the angle ⁇ 1 formed by the extension line L and the central axis C is 27 °
- the angle ⁇ 2 formed by the extension line L and the table T is 7 °.
- the test piece 12 mounted on the tip mounting portion 30 is separated from the table T, and no unnecessary external force is applied to the test piece 12.
- the lower surface of the main portion 44 and the lower surface of the relay portion 46 are connected by a continuous curved surface portion 50 that is concave in a side view.
- a finger hooking protrusion 52 is provided in the vicinity of the base end side when viewed from the curved surface portion 50.
- the finger hooking protrusion 52 has a low triangular shape in a side view, forms a smooth substantially circular arc together with the curved surface portion 50, and has a space enough for one finger to enter.
- the curvature radius of the curved surface portion is preferably 5 mm to 25 mm because it is easy to apply a finger, and more preferably 8 mm to 20 mm. It is easy to put a finger on such a curved surface portion 50 and to easily hold the blood glucose meter 10a.
- the blood glucose meter 10a can be stably held by placing a finger (for example, an index finger) on the curved surface portion 50.
- a finger for example, an index finger
- the curved portion 50 having a concave bottom surface is provided at the connecting portion between the main portion 44 and the relay portion 46, the blood glucose meter 10a is stabilized by being touched by a finger, and is optically controlled by the barcode reader 48. Reading is performed stably.
- the data reading button 40 is substantially opposite to the curved surface portion 50, and is stably held between a finger (for example, an index finger) applied to the curved surface portion 50 and a finger (for example, a thumb) that presses the data reading button 40. Gripping and manipulation becomes possible.
- the concave curved surface portion 50 can be used as a gripping portion, and since it is close to the tip mounting portion 30, it is easy to match the spotting portion 22 to the blood ball 60, and a stable operation is possible.
- the distance H1 between the spotting part 22 and the table T in the blood glucose meter 10a is 13 mm, and the distance H2 between the highest point P on the lower surface and the table T is 11 mm.
- the highest point P is a part of the curved surface portion 50.
- the spotting part 22 is a part to be operated at the time of blood glucose measurement, visibility at the time of operation is required, and visibility is also required for status confirmation when it is placed on the table T. Although it is preferable to keep the spotting part 22 away from the table T, it is not rational to make it leave wastefully. Furthermore, as will be described later (see FIGS. 12 and 13), there is a preferable range of the distance H1 in consideration of the spotting operation with the blood glucose meter 10a placed on the table T. From such a viewpoint, the distance H1 is set in the range of 3 mm to 30 mm, preferably in the range of 9 mm to 14 mm.
- the distance H2 is in the range of 3 mm to 20 mm. Preferably, it is set in the range of 7 mm to 12 mm.
- the blood glucose meter 10 a is turned on, and a predetermined barcode displayed on the individual package of the test piece 12 is read by the barcode reader 48.
- the medical worker 62 operates by pressing the data reading button 40 with the bar code reader 48 facing the card on which the bar code 62b indicating his / her operator identification data is recorded. Read person identification data. The data is recorded together with the blood glucose measurement value, and is used, for example, for checking the traceability of the procedure.
- the barcode reader 48 is provided on the opposite side of the test piece 12, and the data reading button 40 is provided at a position where it can be easily operated with a thumb or the like, the blood component measurement operation and data reading are performed. There is no need to change the hand position during operation, which is efficient.
- the patient identification data of the patient 64 shown on the wristband 64 a is read by the barcode reader 48.
- the measured blood glucose level can be distinguished and stored for each patient.
- the blood glucose meter 10a shifts to the measurement mode after reading the patient identification data, the measurer identification data, and the test piece identification data in this way.
- the cap 39 is removed, and the test piece 12 is pushed into the tip mounting portion 30 together with the case of the individual package until a click is felt, and then only the case is removed. As a result, the test piece 12 is mounted on the tip mounting portion 30.
- the measurement unit 32 displays “OK” on the monitor 34 and automatically shifts to the blood glucose measurement mode. Further, puncture is performed with a predetermined puncture device, and a blood ball 60 is provided on the fingertip (hereinafter, referred to as the left index finger).
- the patient performs a spotting operation in which the spotting portion 22 of the test piece 12 is brought into contact with the blood ball 60 in a state where the blood glucose meter 10a is held with the right hand. At this time, the left and right wrists or the vicinity thereof are placed on the table T to be stabilized.
- the operation at this time is simple, for example, by simply twisting both wrists inward, and can be performed stably with the wrists placed on the table T. Therefore, even when the fingers are inconvenient or unfamiliar with the operation of the blood glucose meter 10a, the small blood ball 60 and the spotting portion 22 are correctly brought into contact with each other without shaking the fingertips, and reliable spotting is achieved. Action is taken. Since the protrusion 18 and the central axis C are in contact with the blood ball 60 directed, the blood ball 60 is prevented from adhering to the periphery of the spotting portion 22, the side surface of the protrusion 18, or the flange 16. it can.
- the blood glucose meter 10a is placed on the table T, while one finger 68 (for example, index finger) on which the blood ball 60 is formed is placed on the table T.
- the blood glucose meter 10a may be brought close to the head while being placed on the head.
- the distance H1 from the table T of the spotting portion 22 is 13 mm.
- the height of the blood ball 60 is generally in the range of 3 mm to 20 mm, usually about 5 mm to 14 mm. Since the height can be adjusted in such a range, it is easy to match the height to the spotting portion 22, and the spotting portion 22 is easily spotted on the blood ball 60. At this time, since the finger 68 and the blood glucose meter 10a are directly placed on the table T, they are extremely stable, and a reliable spotting operation is performed.
- one finger 69 (for example, the middle finger) adjacent to the finger 68 on which the blood ball 60 is formed may be placed on the table T, and the finger 68 may be placed thereon.
- the height of the blood ball 60 on the upper finger 68 varies depending on how the fingers are assembled, how the fingers are placed, etc., and is generally in the range of 5 mm to 30 mm, usually 9 mm to Since the orientation and height of the finger 68 can be adjusted in such a range even if it is about 20 mm and not initially 13 mm, it is easy to match the height with respect to the spotting portion 22, The spotting part 22 can be easily spotted on the blood ball 60.
- the blood glucose meter 10a is directly placed on the table T, it is extremely stable.
- the finger 68 is placed on the finger 69, is reasonably stable, and a reliable spotting operation is performed.
- the distance H1 from the table T to the spotting portion 22 is preferably set in the range of 3 mm to 30 mm, preferably in the range of 9 mm to 14 mm, which is the height corresponding to one finger or two fingers. It is.
- the spotting operation may be performed in the air without using the table T when there is no concern such as shaking of the hand.
- the blood ball 60 is sucked into the blood introduction path 24 by capillary action, a sufficient amount is impregnated in the test paper 20, and a color reaction is shown according to the blood sugar level by the reagent.
- the measurement unit 32 observes the color reaction of the test paper 20, and when the color reaction is stable, the control unit 33 obtains a blood sugar level by a predetermined calculation based on the color reaction and displays it on the monitor 34. At the same time, the buzzer notifies the end of the measurement.
- the scheduled time until the end of the measurement may be displayed on the monitor 34 to indicate the progress of the measurement.
- test piece 12 is covered with a cover of the individual package, the ejector lever 36 is operated, the test piece 12 is removed together with the cover, the power is turned off, and the tip mounting portion Put cap 39 on 30.
- the operation method shown in FIGS. 10 to 13 is for personal use in which the patient himself / herself performs blood glucose measurement.
- the medical worker 62 operates the blood glucose meter 10a.
- the relay part 46 is bent downward with respect to the main part 44. Therefore, even if the relay part 46 is angled to some extent, 44 is substantially horizontal, the medical worker 62 can grasp the blood glucose meter 10a in an easy posture with the elbows lowered, and the palm 66 is visible without the blood ball 60 and the spotted portion 22 becoming blind spots. Excellent in properties.
- FIG. 14 shows a case where the medical worker 62 performs a spotting operation on the patient 64 sleeping on the bed 63.
- the process shown in FIG. 8, the process shown in FIG. 9, and the subsequent blood glucose measurement process may be performed in any order. Any one or more of the identification data reading processes may be performed. Further, it may be configured such that data can be read while blood sugar is measured.
- the test piece 12 is provided on the tip mounting portion 30, and the barcode reader 48 is provided on the opposite rear end surface. Even if the data reading button 40 is pressed, the scanning laser beam is not emitted toward the patient, and the patient does not feel uncomfortable. As shown in FIG. 9, when reading patient identification data, the laser may face the direction of the patient. At this time, the user is operating while paying careful attention to laser reading, and the laser is wristband 64a. And at least the laser will not be directed to the patient's face.
- the test piece 12 may be applied to some other object when the barcode reader 48 is read. There is no. That is, before blood sugar level measurement, the spotting part 22 of the test piece 12 is not soiled or damaged, and correct measurement is performed. After blood glucose level measurement, blood adheres to the spotting part 22, but blood does not adhere to other objects and become dirty.
- the monitor 34 is arranged behind the data reading button 40, and the relay portion 46 and the tip mounting portion 30 on the distal end side thereof are appropriately thin and light and have a good balance. By gripping the curved surface portion 50, the nearby test piece 12 can be stabilized (see FIG. 7).
- the blood glucose level measurement operation using the test piece 12 and the data reading operation using the barcode reader 48 are clearly different, and erroneous operation is prevented.
- the barcode reader 48 as the data reading optical means, it is possible to read data easily without contact.
- the data reading optical means is moderately directional, and there is no fear of interference such as radio, so that reliable data reading is possible.
- the curved surface portion 50 having a concave bottom surface is provided at the connection portion between the main portion 44 and the relay portion 46, the blood glucose meter 10a is stabilized by being touched by a finger, and optical reading by the barcode reader 48 is possible. It is performed stably.
- the data read by the barcode reader 48 may be transferred to a predetermined data management computer via a predetermined communication port or a memory card.
- Data such as measured blood glucose level may be transmitted to the management computer by providing data transmission optical means (for example, IrDA (Infrared Data Association)) in combination with the data reading optical means.
- data transmission optical means for example, IrDA (Infrared Data Association)
- the center axis C of the test piece 12 is directed obliquely downward toward the tip side (in other words, By using the extension line L of the display surface of the monitor 34 as a reference, the center axis C is directed obliquely downward toward the tip side), whereby the spotted portion of the test piece is directed in the direction of the blood ball. It becomes easy, the spotting part 22 of the test piece 12 can be contacted easily and reliably with respect to the blood ball 60 obtained by puncture, and a measurement error can be suppressed.
- the angle ⁇ 1 formed by the extension line L and the central axis C may be 10 ° or more, preferably 15 ° or more in order for the spotting portion 22 to point the direction of the blood ball 60 more correctly.
- the angle ⁇ 1 when the angle ⁇ 1 is increased, the relay unit 46 is excessively downward, so that the visibility of the spotting unit 22 is deteriorated when the blood glucose meter 10a is gripped and placed, and the stability is impaired. There is a concern that the wearing part 22 may not be oriented in the direction of the blood ball 60 or the test piece 12 may come into contact with the table T during placement. Therefore, the angle ⁇ 1 may be 40 ° or less, preferably 30 ° or less. After all, the angle ⁇ 1 is set in the range of 10 ° to 40 °, preferably in the range of 15 ° to 30 °, taking into consideration the influence on the dimensions of each part.
- blood glucose meters 10b, 10c, and 10d according to modifications will be described.
- the same portions as those of the blood glucose meter 10a are denoted by the same reference numerals, and detailed description thereof is omitted.
- the blood glucose meter 10b according to the first modification is obtained by changing the tip mounting portion 30 of the blood glucose meter 10a to a tip mounting portion 72 so that the test piece 70 can be mounted.
- the test piece 70 has a thin and thin plate shape, and a blood introduction path 74 is provided on the central axis C.
- a conventional product can be applied as it is.
- the blood glucose meter 10b measures the blood glucose level based on the current value obtained by the electrochemical sensor instead of the optical means in the measurement unit 32.
- the central axis C of the test piece 70 is directed obliquely downward toward the distal end, and the angle ⁇ 1 formed by the extension line L and the central axis C is 27 °. Is set to
- the blood glucose meter 10c according to the second modification is for personal use, and the number of buttons in the operation button group 38 is smaller than that of the blood glucose meter 10a. There is no reading button 40 (auxiliary function button), and the size is small. The monitor 76 that displays the blood glucose level is smaller than the monitor 34.
- the angle ⁇ 1 formed by the extension line L and the central axis C is 18 °
- the angle ⁇ 2 is 5 °
- H1 is 10 mm
- H2 is related to the dimensions of each part. It is set to 7 mm.
- the blood glucose meter 10 d has a small and thin shape suitable for carrying, has no portion corresponding to the relay unit 46, and has a tip mounting portion 30 on the tip end surface 78. Is provided.
- the tip end surface 78 has a shape inclined obliquely in a side view (a side view is omitted), and the center axis C of the test piece 12 is directed toward the tip with reference to the extension line L of the display surface of the monitor 80. It is directed diagonally downward.
- the central axis C of the test piece 12 is based on the extension line L as in the blood glucose meter 10a. It is directed diagonally downward toward the tip side. Therefore, in any case of hospital use or personal use, the spotting portion 22 of the test piece 12 (or the test piece 70) can be easily oriented in the direction of the blood ball 60, and the blood ball 60 obtained by the puncture can be directed. The spotting part 22 can be contacted easily and reliably, and measurement errors can be suppressed.
- the blood glucose meters 10a to 10d measure the blood glucose level as a characteristic of the sample, but are not limited to this, and can also be applied as a device (blood component measuring device) that measures hormone concentration, cholesterol concentration, and the like.
- the barcode reader 48 in the blood glucose meters 10a and 10b may be other data reading optical means, and may be any of a manual scanning method, a CCD scanning method, a laser scanning method, an image sensing method, and the like.
- the scanning method using a CCD camera makes it possible to read a two-dimensional code, increasing the amount of information that can be read.
- a predetermined prescription information or the like may be read and collated with the measured blood glucose level to obtain the insulin dose.
- the type of data read by the barcode reader 48 is not limited to the above example.
- the blood component measuring apparatus is not limited to the above-described embodiment, but can of course have various configurations without departing from the gist of the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Heart & Thoracic Surgery (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Plasma & Fusion (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Human Computer Interaction (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Claims (24)
- 試験片が装着される血液成分測定装置(12a、12b、12c、12d)において、
前記試験片(12、70)が装着される先端装着部(30、72)と、
前記先端装着部(30、72)に装着された前記試験片(12、70)における血液導入路(24、74)を介して採取された血液の成分を測定する測定部(32)と、
前記測定部(32)及び所定の制御部(33)によって求められた結果を表示するモニタ(34、76、80)と、
を有し、
前記モニタ(34、76、80)の表示面を上側、その反対側を下側とし、
前記モニタ(34、76、80)の表示面を上向きとして水平面に載置したときに、前記試験片(12、70)の中心軸線は先端側に向けて斜め下方を指向していることを特徴とする血液成分測定装置(12a、12b、12c、12d)。 - 請求項1記載の血液成分測定装置(12a、12b、12c)において、
前記モニタ(34、76)が設けられる主部(44)と、
前記主部(44)と前記先端装着部(30、72)との間に設けられる中継部(46)と、
を有し、
前記中継部(46)の上面(46a)は、前記中心軸線と略平行に設定されていることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項2記載の血液成分測定装置(12a、12b、12c)において、
前記中継部(46)の上面(46a)には、先端側に向かって押し出し操作をすることによって、装着された前記試験片(12、70)を取り外すイジェクタレバー(36)が設けられていることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項2記載の血液成分測定装置(12a、12b、12c)において、
上面視で、前記中継部(46)は、前記主部(44)から連続的且つ凹状に、先端側へ向かって狭幅になっていることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項2記載の血液成分測定装置(12a、12b、12c)において、
前記主部(44)は、上下方向の厚みが略一定で、
側面視で、前記主部(44)と前記中継部(46)は、下面が凹状の連続的な曲面部(50)で接続されていることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項5記載の血液成分測定装置(12a、12b、12c)において、
前記先端装着部(30、72)に前記試験片(12、70)を装着し、前記モニタ(34、76)の表示面を上向きとして水平面に載置したときに、前記試験片(12、70)における先端の点着部(22)と前記水平面との距離が3mm~30mmであることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項1記載の血液成分測定装置(12a、12b、12c)において、
前記モニタ(34、76)の表示面を上向きとして水平面に載置したときに、下面における最高点と前記水平面との距離が3mm~20mmであることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項1記載の血液成分測定装置(12a、12b、12c、12d)において、
前記先端装着部(30、72)に前記試験片(12、70)を装着し、前記モニタ(34、76)の表示面を上向きとして水平面に載置したときに、前記試験片(12、70)は前記水平面から離間していることを特徴とする血液成分測定装置(12a、12b、12c、12d)。 - 試験片が装着される血液成分測定装置(12a、12b、12c、12d)において、
前記試験片(12、70)が装着される先端装着部(30、72)と、
前記先端装着部(30、72)に装着された前記試験片(12、70)における血液導入路(24、74)を介して採取された血液の成分を測定する測定部(32)と、
前記測定部(32)及び所定の制御部(33)によって求められた結果を表示するモニタ(34、76、80)と、
を有し、
前記モニタ(34、76、80)の表示面を上側、その反対側を下側とし、
側面視で、前記モニタの表示面の延長線を基準として、前記試験片(12、70)の中心軸線は先端側に向けて斜め下方を指向していることを特徴とする血液成分測定装置(12a、12b、12c、12d)。 - 請求項9記載の血液成分測定装置(12a、12b、12c、12d)において、
前記延長線と前記中心軸線とのなす角度は10°~40°であることを特徴とする血液成分測定装置(12a、12b、12c、12d)。 - 請求項9記載の血液成分測定装置(12a、12b、12c)において、
前記モニタ(34、76)が設けられる主部と(44)、
前記主部(44)と前記先端装着部(30、72)との間に設けられる中継部(46)と、
を有し、
前記中継部(46)の上面(46a)は、前記中心軸線と略平行に設定されていることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項11記載の血液成分測定装置(12a、12b、12c)において、
前記中継部(46)の上面(46a)には、先端側に向かって押し出し操作をすることによって、装着された前記試験片(12、70)を取り外すイジェクタレバー(36)が設けられていることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項11記載の血液成分測定装置(12a、12b、12c)において、
上面視で、前記中継部(46)は、前記主部(44)から連続的且つ凹状に、先端側へ向かって狭幅になっていることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項11記載の血液成分測定装置(12a、12b、12c)において、
前記主部(44)は、上下方向の厚みが略一定で、
側面視で、前記主部(44)と前記中継部(46)は、下面が凹状の連続的な曲面部(50)で接続されていることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項14記載の血液成分測定装置(12a、12b、12c)において、
前記先端装着部(30、72)に前記試験片(12、70)を装着し、前記モニタ(34、76)の表示面を上向きとして水平面に載置したときに、前記試験片(12、70)における先端の点着部(22)と前記水平面との距離が3mm~30mmであることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項9記載の血液成分測定装置(12a、12b、12c)において、
前記モニタ(34、76)の表示面を上向きとして水平面に載置したときに、下面における最高点と前記水平面との距離が3mm~20mmであることを特徴とする血液成分測定装置(12a、12b、12c)。 - 請求項9記載の血液成分測定装置(12a、12b、12c、12d)において、
前記先端装着部(30、72)に前記試験片(12、70)を装着し、前記モニタ(34、76)の表示面を上向きとして水平面に載置したときに、前記試験片(12、70)は前記水平面から離間していることを特徴とする血液成分測定装置(12a、12b、12c、12d)。 - 試験片が装着される血液成分測定装置(12a、12b)において、
前記試験片(12、70)が装着される先端装着部(30、72)と、
前記先端装着部(30、72)に装着された前記試験片(12、70)における血液導入路(24、74)を介して採取された血液の成分を測定する測定部(32)と、
前記測定部(32)及び所定の制御部(33)によって求められた結果を表示するモニタ(34)と、
後端に設けられたデータ読取光学手段(48)と、
前記モニタ(34)が設けられる主部(44)と、
前記主部(44)と前記先端装着部(30、72)との間に設けられる中継部(46)と、
前記主部(44)と前記中継部(46)との接続箇所で、側面視で下面が凹状の曲面部(50)と、
を有することを特徴とする血液成分測定装置(12a、12b)。 - 請求項18記載の血液成分測定装置(12a、12b)において、
前記モニタ(34)が設けられる側の面で、前記モニタ(34)と前記先端装着部(30、72)との間に、前記データ読取光学手段の操作スイッチ(40)を有することを特徴とする血液成分測定装置(12a、12b)。 - 請求項18記載の血液成分測定装置(12a、12b)において、
前記データ読取光学手段は、バーコードリーダであることを特徴とする血液成分測定装置(12a、12b)。 - 請求項18記載の血液成分測定装置(12a、12b)において、
前記データ読取光学手段(48)は、2次元コードを読み取るカメラであることを特徴とする血液成分測定装置(12a、12b)。 - 請求項18記載の血液成分測定装置(12a、12b)において、
上面視で、前記中継部(46)は、前記主部(44)から連続的且つ凹状に、先端側へ向かって狭幅になっていることを特徴とする血液成分測定装置(12a、12b)。 - 請求項18記載の血液成分測定装置(12a、12b)において、
前記曲面部(50)の曲率半径は、5mm~25mmであることを特徴とする血液成分測定装置(12a、12b)。 - 請求項18記載の血液成分測定装置(12a、12b)において、
前記モニタ(34)の表示面を上側、その反対側を下側とし、
側面視で、前記モニタ(34)の表示面の延長線を基準として、前記試験片(12、70)の中心軸線は先端側に向けて斜め下方を指向していることを特徴とする血液成分測定装置(12a、12b)。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09827596.9A EP2352031A4 (en) | 2008-11-21 | 2009-11-19 | DEVICE FOR MEASURING BLOOD COMPONENTS |
US13/129,945 US8647575B2 (en) | 2008-11-21 | 2009-11-19 | Device for measuring blood component |
BRPI0921997A BRPI0921997B8 (pt) | 2008-11-21 | 2009-11-19 | dispositivo para medição do componente de sangue |
CN200980145682.2A CN102216782B (zh) | 2008-11-21 | 2009-11-19 | 血液成分测定装置 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008297869A JP5320038B2 (ja) | 2008-11-21 | 2008-11-21 | 血液成分測定装置 |
JP2008-297869 | 2008-11-21 | ||
JP2009050494A JP5320111B2 (ja) | 2009-03-04 | 2009-03-04 | 血液成分測定装置 |
JP2009-050494 | 2009-03-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010058815A1 true WO2010058815A1 (ja) | 2010-05-27 |
Family
ID=42198254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2009/069622 WO2010058815A1 (ja) | 2008-11-21 | 2009-11-19 | 血液成分測定装置 |
Country Status (5)
Country | Link |
---|---|
US (1) | US8647575B2 (ja) |
EP (1) | EP2352031A4 (ja) |
CN (1) | CN102216782B (ja) |
BR (1) | BRPI0921997B8 (ja) |
WO (1) | WO2010058815A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2634582A1 (en) * | 2010-10-28 | 2013-09-04 | Panasonic Corporation | Living specimen measurement device |
CN103492880A (zh) * | 2011-03-31 | 2014-01-01 | 泰尔茂株式会社 | 血糖值管理系统 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012018486A2 (en) | 2010-07-26 | 2012-02-09 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
ES2550668T3 (es) * | 2010-08-13 | 2015-11-11 | Seventh Sense Biosystems, Inc. | Técnicas y dispositivos clínicos y/o del consumidor |
WO2012021801A2 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
WO2012149126A1 (en) | 2011-04-29 | 2012-11-01 | Seventh Sense Biosystems, Inc. | Plasma or serum production and removal of fluids under reduced pressure |
MX2014015052A (es) * | 2012-06-12 | 2015-03-03 | Koninkl Philips Nv | Sistema para medicion de signos vitales basado en camara. |
WO2014006827A1 (ja) * | 2012-07-02 | 2014-01-09 | コニカミノルタ株式会社 | 黄疸計 |
DE102012014503A1 (de) | 2012-07-20 | 2014-01-23 | Dräger Safety AG & Co. KGaA | Gasmesssystem |
JP6391469B2 (ja) * | 2013-01-25 | 2018-09-19 | テルモ株式会社 | 血糖計 |
TWM478427U (zh) * | 2013-11-06 | 2014-05-21 | Jun-Tong Chen | 防誤插之血液測試機 |
JP6442826B2 (ja) * | 2013-12-27 | 2018-12-26 | セイコーエプソン株式会社 | 血液成分分析方法および血液成分分析装置 |
USD793257S1 (en) * | 2015-08-26 | 2017-08-01 | Mettler-Toledo Gmbh | Handheld measuring instrument |
WO2018027935A1 (en) * | 2016-08-12 | 2018-02-15 | Medtrum Technologies Inc. | A pen-shaped one-step apparatus for body fluid sampling and sensing |
EP3315069A1 (en) * | 2016-10-25 | 2018-05-02 | Roche Diabetes Care GmbH | Method for determination of an analyte concentration in a body fluid and analyte concentration measurement device |
BR112022019537A2 (pt) * | 2020-04-03 | 2022-11-16 | Bruin Biometrics Llc | Sensor de biocapacitância |
USD949343S1 (en) * | 2020-08-27 | 2022-04-19 | Andon Health Co., Ltd. | Blood glucose monitor |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03135393A (ja) | 1989-10-17 | 1991-06-10 | Sankyo Seiki Mfg Co Ltd | 3相正弦波信号合成回路及びブラシレスモータの駆動回路 |
JPH11332378A (ja) * | 1998-05-28 | 1999-12-07 | Nagayama:Kk | 青果熟度計 |
JP2000046834A (ja) | 1998-07-24 | 2000-02-18 | Terumo Corp | 血糖値測定方法及び装置 |
JP2001021556A (ja) * | 1999-07-12 | 2001-01-26 | Terumo Corp | 体液成分測定具 |
US7077328B2 (en) | 1998-07-31 | 2006-07-18 | Abbott Laboratories | Analyte test instrument system including data management system |
JP2006517651A (ja) * | 2002-11-26 | 2006-07-27 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | 体液検査装置 |
JP2007054407A (ja) * | 2005-08-25 | 2007-03-08 | Terumo Corp | 穿刺装置及び穿刺針チップ |
JP2007068839A (ja) * | 2005-09-08 | 2007-03-22 | Terumo Corp | 婦人用電子体温計、婦人用電子体温計の制御方法並びに制御プログラム |
WO2007118046A2 (en) * | 2006-04-03 | 2007-10-18 | Home Diagnostics, Inc. | Diagnostic meter |
WO2008087876A1 (ja) * | 2007-01-19 | 2008-07-24 | Terumo Kabushiki Kaisha | 成分測定装置 |
JP2008535599A (ja) * | 2005-04-12 | 2008-09-04 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | 携帯電話への医療用ソフトウェアのダウンロード |
JP2008200438A (ja) * | 2007-02-22 | 2008-09-04 | National Institute Of Advanced Industrial & Technology | 針一体型センサ |
WO2009099148A1 (ja) * | 2008-02-07 | 2009-08-13 | Arkray, Inc. | コード読み取り装置およびこれを用いたデータ収集システム |
JP3155842U (ja) * | 2009-09-18 | 2009-12-03 | テルモ株式会社 | 成分測定装置 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5801918A (en) * | 1996-07-12 | 1998-09-01 | Hand Held Products, Inc. | Ergonomic housing for a micro computer |
US6493069B1 (en) | 1998-07-24 | 2002-12-10 | Terumo Kabushiki Kaisha | Method and instrument for measuring blood sugar level |
US7572237B2 (en) * | 2002-11-06 | 2009-08-11 | Abbott Diabetes Care Inc. | Automatic biological analyte testing meter with integrated lancing device and methods of use |
CN100401049C (zh) * | 2003-01-27 | 2008-07-09 | 泰尔茂株式会社 | 体液成分分析系统 |
JP2004347436A (ja) * | 2003-05-21 | 2004-12-09 | Terumo Corp | 成分測定装置 |
CA2563530C (en) * | 2004-04-16 | 2013-12-17 | Becton, Dickinson And Company | Blood glucose meter having integral lancet device and test strip storage vial for single handed use and methods for using same |
US20060078658A1 (en) * | 2004-10-04 | 2006-04-13 | Owens Megan M | Food quality sensor and methods thereof |
WO2007057704A1 (en) * | 2005-11-21 | 2007-05-24 | Inverness Medical Switzerland Gmbh | Test device |
CN101176666A (zh) * | 2006-11-09 | 2008-05-14 | 李仁方 | 具采血枪结构的血糖检测仪器 |
EP2090227A4 (en) | 2006-11-10 | 2010-01-27 | Nat Inst Of Advanced Ind Scien | BIOSENSOR CARTRIDGE, BIOSENSOR DEVICE, TAKEOVER PROCESS, METHOD OF MANUFACTURING A BIOSENSOR CARTRIDGE AND NEEDLE INTEGRATED SENSOR |
JP3135393U (ja) | 2007-07-03 | 2007-09-13 | テルモ株式会社 | 操作補助具 |
-
2009
- 2009-11-19 US US13/129,945 patent/US8647575B2/en active Active
- 2009-11-19 CN CN200980145682.2A patent/CN102216782B/zh active Active
- 2009-11-19 WO PCT/JP2009/069622 patent/WO2010058815A1/ja active Application Filing
- 2009-11-19 EP EP09827596.9A patent/EP2352031A4/en not_active Withdrawn
- 2009-11-19 BR BRPI0921997A patent/BRPI0921997B8/pt active IP Right Grant
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03135393A (ja) | 1989-10-17 | 1991-06-10 | Sankyo Seiki Mfg Co Ltd | 3相正弦波信号合成回路及びブラシレスモータの駆動回路 |
JPH11332378A (ja) * | 1998-05-28 | 1999-12-07 | Nagayama:Kk | 青果熟度計 |
JP2000046834A (ja) | 1998-07-24 | 2000-02-18 | Terumo Corp | 血糖値測定方法及び装置 |
US7077328B2 (en) | 1998-07-31 | 2006-07-18 | Abbott Laboratories | Analyte test instrument system including data management system |
JP2001021556A (ja) * | 1999-07-12 | 2001-01-26 | Terumo Corp | 体液成分測定具 |
JP2006517651A (ja) * | 2002-11-26 | 2006-07-27 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | 体液検査装置 |
JP2008535599A (ja) * | 2005-04-12 | 2008-09-04 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | 携帯電話への医療用ソフトウェアのダウンロード |
JP2007054407A (ja) * | 2005-08-25 | 2007-03-08 | Terumo Corp | 穿刺装置及び穿刺針チップ |
JP2007068839A (ja) * | 2005-09-08 | 2007-03-22 | Terumo Corp | 婦人用電子体温計、婦人用電子体温計の制御方法並びに制御プログラム |
WO2007118046A2 (en) * | 2006-04-03 | 2007-10-18 | Home Diagnostics, Inc. | Diagnostic meter |
WO2008087876A1 (ja) * | 2007-01-19 | 2008-07-24 | Terumo Kabushiki Kaisha | 成分測定装置 |
JP2008200438A (ja) * | 2007-02-22 | 2008-09-04 | National Institute Of Advanced Industrial & Technology | 針一体型センサ |
WO2009099148A1 (ja) * | 2008-02-07 | 2009-08-13 | Arkray, Inc. | コード読み取り装置およびこれを用いたデータ収集システム |
JP3155842U (ja) * | 2009-09-18 | 2009-12-03 | テルモ株式会社 | 成分測定装置 |
Non-Patent Citations (1)
Title |
---|
See also references of EP2352031A4 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2634582A1 (en) * | 2010-10-28 | 2013-09-04 | Panasonic Corporation | Living specimen measurement device |
EP2634582A4 (en) * | 2010-10-28 | 2014-02-26 | Panasonic Corp | DEVICE FOR MEASURING LIVE SPECIMENS |
JP5778167B2 (ja) * | 2010-10-28 | 2015-09-16 | パナソニックヘルスケアホールディングス株式会社 | 生体試料測定装置 |
US9188466B2 (en) | 2010-10-28 | 2015-11-17 | Panasonic Healthcare Holdings Co., Ltd. | Biological sample measuring device |
CN103492880A (zh) * | 2011-03-31 | 2014-01-01 | 泰尔茂株式会社 | 血糖值管理系统 |
Also Published As
Publication number | Publication date |
---|---|
CN102216782A (zh) | 2011-10-12 |
BRPI0921997A2 (pt) | 2016-01-05 |
US20110223078A1 (en) | 2011-09-15 |
CN102216782B (zh) | 2014-07-09 |
BRPI0921997B1 (pt) | 2020-09-29 |
EP2352031A4 (en) | 2014-12-31 |
EP2352031A1 (en) | 2011-08-03 |
BRPI0921997B8 (pt) | 2021-07-27 |
US8647575B2 (en) | 2014-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010058815A1 (ja) | 血液成分測定装置 | |
JP4625062B2 (ja) | 補助具 | |
JP5713104B2 (ja) | 携帯機器 | |
CA1277896C (en) | Medical system | |
US7818132B2 (en) | Test system | |
JP2004351107A (ja) | 携帯式医療用測定装置 | |
JP5320111B2 (ja) | 血液成分測定装置 | |
US20050126938A1 (en) | Integrally storable adaptor | |
US11064923B2 (en) | Liquid sample measurement device with removable lancet or biosensor | |
JP5320038B2 (ja) | 血液成分測定装置 | |
JP5694830B2 (ja) | 成分測定装置、医療機器及び音声ガイダンス方法 | |
JP5968314B2 (ja) | 成分測定装置 | |
CN104680609B (zh) | 基于虚拟现实技术的多功能考勤装置及使用其的方法 | |
JP4555001B2 (ja) | 携帯型生体信号測定装置 | |
EP2634582B1 (en) | Biological sample measuring device | |
JP2012075628A (ja) | 体液成分測定装置 | |
JP3137887U (ja) | 固定具 | |
JP2012095949A (ja) | 体液成分測定装置 | |
JP2013076598A (ja) | 医療機器、エラー情報処理システム及びエラー情報処理プログラム | |
JP2005237497A (ja) | 血液点着補助部を備えた成分測定装置 | |
JP2018000298A (ja) | 携帯型生体情報表示装置および携帯型生体情報測定装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980145682.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09827596 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13129945 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009827596 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: PI0921997 Country of ref document: BR Kind code of ref document: A2 Effective date: 20110520 |